Optune™ is a unique new form of treatment for brain tumors: it uses Tumor Treating Fields (TTF) to kill dividing cells. These fields are delivered by removable transducer arrays that are placed on the head.
This was approved by the United States FDA in 2011 for use in patients with recurrent glioblastoma multiforme and in 2015 for use in patients with newly diagnosed glioblastoma multifore
Tumor Treating Fields have been added to the NCCN guidelines as the standard of care for treatment of recurrent glioblastom multiform. See http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (free registration is required).
Click HERE for a news video about the Novocure NovoTTF-100A!
Click on the links below for more information on Optune!
Disclosure: the Novocure company is a sponsor of our organization!